Showing 631-640 of 1232 results for "".
Glaucoma Through a Legislative Lens
https://modernod.com/topics/glaucoma/glaucoma-through-a-legislative-lens/38552/Taking stock of the changing times and change in scope of practice for optometrists.How Genetics Factor Into Corneal Disease
https://modernod.com/mod-issues/2022-mar/how-genetics-factor-into-corneal-disease/38392/Genetic testing can assess a patient’s risk of developing keratoconus and inform your treatment plan.The Art and Science of Referrals
https://modernod.com/topics/business/the-art-and-science-of-referrals/39071/Ensure that your patients receive the care they need—even when it falls outside of your practice pattern or capability.Road Map for Success: How to Manage Dry Eye in Your Practice
https://modernod.com/topics/ocular-surface/road-map-for-successhow-to-manage-dry-eye-in-your-practice/37960/Pearls for managing dry eye disease for seasoned veterans and novices alike.Dry Eye Cases From a Collaborative Clinic
https://modernod.com/topics/cataractrefractive-surgery/dry-eye-cases-from-a-collaborative-clinic/39163/Using all of the tools in the dry eye toolbox.Evolving Concepts in Anterior Segment Outcomes: Tackling Ocular Surface Disease, Comanaging Premium IOL Patients, and Identifying New Keratoconus Treatments
https://modernod.com/topics/ocular-surface/evolving-concepts-in-anterior-segment-outcomes-tackling-ocular-surface-disease-comanaging-premium-iol-patients-and-identifying-new-keratoconus-treatments/38100/TFOS DEWS III Published
https://modernod.com/podcasts/eyewire-news-the-podcast/tfos-dews-iii-published/37089/The Tear Film and Ocular Surface Society publishes the third installment of the TFOS DEWS report; J&J launches the Tecnis Odyssey presbyopia-correcting IOL in Europe, the Middle East, and Canada; and Harrow acquires the exclusive US commercial rights to postoperative inflammation and pain drug B2. Myopia Control: Treatment Options and Upcoming Research
https://modernod.com/podcasts/four-eyes/2-myopia-control-treatment-options-and-upcoming-research/36952/We review treatment options related to myopia control including the new FDA approved lenses MiSight 1-Day by CooperVision, and share upcoming research in this area from Keyur Savla, BOptom and Celia Gong, OD.Resources:1. Review of Optometry Article on Myopia Treatments: https://www.reviewofoptometryBilling and Coding for the Optometric Practice
https://modernod.com/topics/glaucoma/billing-and-coding-for-the-optometric-practice/38488/Key takeaways from the optometric business management session at the MOD Live 2022 meeting held in Nashville, Tennessee.GA Case Compendium: Simultaneous Development of Geographic Atrophy and Wet AMD in a Patient Lost to Follow-up
https://modernod.com/resources/geographic-atrophy-case-compendium/simultaneous-development-of-geographic-atrophy-and-wet-amd-in-a-patient-lost-to-follow-up/39243/